Cargando…
Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma
The overexpression of macrophage migration inhibitory factor (MIF) has been identified in a variety of tumors and the investigation of its molecular mechanisms in tumor progression is a key topic of research. The present study aimed to investigate MIF as a potential marker for disease control or rec...
Autores principales: | DE SOUZA, MARIANA BARBOSA, CURIONI, OTÁVIO ALBERTO, KANDA, JOSSI LEDO, DE CARVALHO, MARCOS BRASILINO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186499/ https://www.ncbi.nlm.nih.gov/pubmed/25289107 http://dx.doi.org/10.3892/ol.2014.2513 |
Ejemplares similares
-
How useful is the assessment of lymphatic vascular density in oral carcinoma prognosis?
por: Longatto Filho, Adhemar, et al.
Publicado: (2007) -
Complete pathologic response as a prognostic factor for squamous cell carcinoma of the oropharynx post-chemoradiotherapy()
por: Trufelli, Damila Cristina, et al.
Publicado: (2015) -
Macrophage migration inhibitory factor: A promising oncogenic
serological biomarker for oral squamous cell carcinoma
por: Zepeda-Nuño, José Sergio, et al.
Publicado: (2021) -
Quality of life impairment in patients with head and neck cancer and their caregivers: a comparative study()
por: Rigoni, Laís, et al.
Publicado: (2016) -
Serum Macrophage Migration Inhibitory Factor as a Biomarker of Active Pulmonary Tuberculosis
por: Shang, Zhong-bo, et al.
Publicado: (2018)